Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1752 results

California outlaws pay-for-delay deals

US09-10-2019Sarah Morgan

California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

Fed Circuit overturns Apotex’s PTAB victory

US07-10-2019Sarah Morgan

The US Court of Appeals for the Federal Circuit last week reversed a Patent Trial and Appeal Board decision, which found that claims in an OSI Pharmaceuticals patent for cancer treatment were obvious.

US biotech licenses antibody from Takeda for new kidney drugs

Japan, US04-10-2019Rory O'Neill

Goldfinch Bio, a US company focused on developing treatments for kidney disease, has agreed to license a cannabinoid receptor 1 antibody from Japanese pharmaceutical manufacturer Takeda.

USPTO grants new CRISPR-Cas9 patent to University of California

US03-10-2019Rory O'Neill

The US Patent and Trademark Office (USPTO) has granted a new CRISPR-Cas9 patent to the University of California (UC), the University of Vienna and Emmanuelle Charpentier, marking the fifth consecutive week that the USPTO has approved a new patent in their CRISPR portfolio.

Bausch targets Sandoz over IBS generic

US03-10-2019Rory O'Neill

Canadian pharmaceutical company Bausch Health is suing Sandoz for patent infringement over its notice of intent to release a generic version of Xifaxan, Bausch’s irritable bowel syndrome drug.

Abbott sued for patent infringement over infant probiotic

US03-10-2019Rory O'Neill

Evolve BioSystems and the University of California have jointly sued Abbott Laboratories for patent infringement over a soon-to-be-launched probiotic product.

Taiwanese firm accuses Pacific Biosciences of infringing sequencing tech

Taiwan, US30-09-2019Sarah Morgan

Taiwan-based Personal Genomics Taiwan has taken gene-sequencing rival Pacific Biosciences to court in the US, over alleged patent infringement.

Bayer and Boston hospitals collaborate on COPD lab

US26-09-2019Rory O'Neill

Bayer and two Boston hospitals have joined forces in a chronic lung disease research product, with the trio championing the ‘joint lab’ model as a blueprint for pharmaceutical research.

Greensfelder appoints Missouri-based patent attorney

US26-09-2019Rory O'Neill

Greensfelder, Hemker & Gale has appointed Jared Manse to its St Louis office as an associate in the firm’s IP Practice Group.

Federal Circuit upholds Inter-Cellular PTA delay

US23-09-2019Rory O'Neill

The US Court of Appeals for the Federal Circuit has ruled that delays resulting from challenges to patent examiners’ final decisions will be attributed to the applicant when calculating patent term adjustment.

Showing 1 to 10 of 1752 results